These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19061285)

  • 21. Mammary carcinomas with neuroendocrine features--correct understanding and proper use of the terminology.
    Kawasaki T; Sugai T; Kashiwaba M; Sapino A
    Histopathology; 2015 Apr; 66(5):754-5. PubMed ID: 25252170
    [No Abstract]   [Full Text] [Related]  

  • 22. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas.
    Ordóñez NG
    Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary Neuroendocrine Tumors.
    Borczuk AC
    Surg Pathol Clin; 2020 Mar; 13(1):35-55. PubMed ID: 32005434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forkhead box A2 transcription factor is expressed in all types of neuroendocrine lung tumors.
    Khoor A; Stahlman MT; Johnson JM; Olson SJ; Whitsett JA
    Hum Pathol; 2004 May; 35(5):560-4. PubMed ID: 15138929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
    Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
    Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K
    Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The oncofetal protein IMP3: a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung.
    Del Gobbo A; Vaira V; Guerini Rocco E; Palleschi A; Bulfamante G; Ricca D; Fiori S; Bosari S; Ferrero S
    J Thorac Oncol; 2014 Nov; 9(11):1656-61. PubMed ID: 25144243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
    Travis WD
    Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of neuroendocrine differentiation in lung cancer cell lines featured by cytomorphology, markers, and their corresponding tumors.
    Linnoila RI
    J Cell Biochem Suppl; 1996; 24():92-106. PubMed ID: 8806093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas.
    Yoshimoto T; Motoi N; Yamamoto N; Nagano H; Ushijima M; Matsuura M; Okumura S; Yamaguchi T; Fukayama M; Ishikawa Y
    Neuroendocrinology; 2018; 106(1):47-57. PubMed ID: 28208131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung.
    Song J; Li M; Tretiakova M; Salgia R; Cagle PT; Husain AN
    Arch Pathol Lab Med; 2010 Nov; 134(11):1702-5. PubMed ID: 21043826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas.
    Pelosi G; Masullo M; Leon ME; Veronesi G; Spaggiari L; Pasini F; Sonzogni A; Iannucci A; Bresaola E; Viale G
    Virchows Arch; 2004 Nov; 445(5):449-55. PubMed ID: 15375659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung.
    LaPoint RJ; Bourne PA; Wang HL; Xu H
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):401-6. PubMed ID: 18091382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma.
    Kwon SY; Bae YK; Gu MJ; Choi JE; Kang SH; Lee SJ; Kim A; Jung HR; Kang SH; Oh HK; Park JY
    Histopathology; 2014 Apr; 64(5):647-59. PubMed ID: 24117859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinomas of the lung with neuroendocrine differentiation.
    Carter D; Yesner R
    Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids.
    Pelosi G; Pasini F; Fraggetta F; Pastorino U; Iannucci A; Maisonneuve P; Arrigoni G; De Manzoni G; Bresaola E; Viale G
    Lung Cancer; 2003 Nov; 42(2):203-13. PubMed ID: 14568688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal p53 expression in lung neuroendocrine tumors. Diagnostic and prognostic implications.
    Roncalli M; Doglioni C; Springall DR; Papotti M; Pagani A; Polak JM; Ibrahim NB; Coggi G; Viale G
    Diagn Mol Pathol; 1992 Jun; 1(2):129-35. PubMed ID: 1364172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung.
    Papotti M; Croce S; Macrì L; Funaro A; Pecchioni C; Schindler M; Bussolati G
    Diagn Mol Pathol; 2000 Mar; 9(1):47-57. PubMed ID: 10718213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD200 Expression in Neuroendocrine Neoplasms.
    Love JE; Thompson K; Kilgore MR; Westerhoff M; Murphy CE; Papanicolau-Sengos A; McCormick KA; Shankaran V; Vandeven N; Miller F; Blom A; Nghiem PT; Kussick SJ
    Am J Clin Pathol; 2017 Sep; 148(3):236-242. PubMed ID: 28821198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.